You are here
HEMOGENIX, LLC
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
An In Vitro Throughput Stem Cell Hemotoxicity Assay
Amount: $0.00DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in per ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
An In Vitro Throughput Stem Cell Hemotoxicity Assay
Amount: $926,630.00DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in per ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
AN IN VITRO HIGH THROUGHPUT STEM CELL HEMOTOXICITY ASSAY
Amount: $120,000.00Present hemotoxicity testing during drug development has a low predictability level. In contrast, the in vitro hematopoietic stem and progenitor cell colony-forming assays (CFA) provide validated and ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health